Arcellx Company

Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Industry: CAR-T
Headquarters: Gaithersburg, Maryland, United States
Founded Date: 2015-01-01
Employees Number: 55
Funding Status: IPO
Investors Number: 24
Total Funding: 209999986
Estimated Revenue: $10M to $50M
Last Funding Date: 2022-03-10
Last Funding Type: Post-IPO Equity

Visit Website
info@arcellx.com
https://twitter.com/biovaxys?lang=en
Register and Claim Ownership